LUZZA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 3.006
EU - Europa 1.566
AS - Asia 1.365
SA - Sud America 28
OC - Oceania 19
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.004
Nazione #
US - Stati Uniti d'America 2.900
SG - Singapore 835
IT - Italia 675
CN - Cina 312
DE - Germania 254
GB - Regno Unito 213
SE - Svezia 142
FI - Finlandia 103
CA - Canada 97
IN - India 65
NL - Olanda 60
IR - Iran 56
JP - Giappone 24
RU - Federazione Russa 22
AU - Australia 17
BR - Brasile 17
HK - Hong Kong 17
TR - Turchia 14
TW - Taiwan 13
FR - Francia 12
CZ - Repubblica Ceca 10
ES - Italia 10
PL - Polonia 10
UA - Ucraina 10
IL - Israele 8
RO - Romania 8
AT - Austria 7
IE - Irlanda 7
MX - Messico 7
EU - Europa 6
PK - Pakistan 6
CL - Cile 5
PH - Filippine 4
RS - Serbia 4
CH - Svizzera 3
GR - Grecia 3
HU - Ungheria 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CI - Costa d'Avorio 2
CU - Cuba 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
ID - Indonesia 2
IQ - Iraq 2
MG - Madagascar 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
BD - Bangladesh 1
EE - Estonia 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
PY - Paraguay 1
TH - Thailandia 1
Totale 6.004
Città #
Chandler 533
Singapore 296
Santa Clara 278
Milan 238
Chicago 222
Princeton 211
Lawrence 210
Munich 202
London 193
Wilmington 132
Ottawa 82
Helsinki 80
Ashburn 72
Des Moines 68
Boardman 41
Shanghai 37
Catanzaro 33
Rome 33
Guangzhou 29
Redwood City 27
Cittanova 22
Hanover 22
Naples 21
Norwalk 19
Pune 19
Mumbai 17
Beijing 16
Redmond 16
The Dalles 14
Shenzhen 13
Bari 12
Mendicino 12
Osaka 12
Jyväskylä 11
Los Angeles 11
Palermo 11
San Nicola Manfredi 10
Cosenza 9
Praia A Mare 9
Council Bluffs 8
Jiaxing 8
São Paulo 8
Tehran 8
Collegeville 7
Dublin 7
Hong Kong 7
Istanbul 7
San Francisco 7
Tokyo 7
Assago 6
Central 6
Horia 6
Jerusalem 6
Vienna 6
Wuhan 6
Clearwater 5
Hangzhou 5
Maletto 5
Montreal 5
Nanjing 5
Olomouc 5
Phoenix 5
Reggio Calabria 5
Siena 5
Taipei 5
Turku 5
Wuxi 5
Zabki 5
Amsterdam 4
Ann Arbor 4
Charlotte 4
Elk Grove Village 4
Potenza 4
Rende 4
Selargius 4
Shenyang 4
Sydney 4
West Jordan 4
Xi'an 4
Alhambra 3
Arequipa 3
Aversa 3
Bade District 3
Belgrade 3
Benevento 3
Bologna 3
Bratislava 3
Brooklyn 3
Catania 3
Changsha 3
Chennai 3
Dongyang 3
Esslingen am Neckar 3
Fairfield 3
Hyderabad 3
Kahramanmaraş 3
L'aquila 3
Miami 3
Miguel Hidalgo 3
Negrar 3
Totale 3.575
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 205
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 147
Dietary polyphenolsand non-alcoholic fatty liver disease 71
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis 64
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 54
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 53
The role of gluten-free diet in nonalcoholic fatty liver disease development 51
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 48
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 48
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 44
7-Ketolithocholic acid administration in man: effects on biliary lipid composition, serum bile acid pattern and evaluation of the cholelitholytic potential 44
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopiche di mucosa gastrica antrale 43
Antral nodularity identifies Helicobacter pylori infected children with higher grades of gastric inflammation 43
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 42
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 42
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 41
Altered IgG4 renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity 41
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 40
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 40
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 39
La calcolosi della colecisti 39
Epidemiology of Coronavirus Disease Outbreak: The Italian Trends. 39
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 39
Bioactive interleukin-18 expression is up-regulated in Crohn’s disease 38
Alcohol consumption survey in an outpatient center of gastroenterology in southern Italy 38
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 38
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. 38
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 37
Ruolo della colonscopia e delle biopsie multiple nella sorveglianza dei pazienti affetti da colite ulcerosa di lunga durata 36
Internal medicine Magna Græcia network for the management of hepatocellular carcinoma. 36
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 36
Ancient wheats: beneficial effects on insulin resistance 36
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 35
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 35
Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathological features 35
High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients 35
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopicher di mucosa gastrica antrale 35
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 35
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 35
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study 35
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 35
Effects of Mediterranean diet supplemented with sylibin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease 35
Antibacterial drugs in Crohn's disease 35
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot study 33
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 33
Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 33
Low prevalence of p-ANCA in unaffected relatives of patients with ulcerative colitis from a Mediterranean area 33
Antral nodularity identifies children infected with Helicobacter pylori with higher grades of gastric inflammation 33
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 33
Gut microbiota and non-alcoholic fatty liver disease 33
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 32
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 32
Circulating D dimer in inflammatory bowel disease 32
Trattamento medico della litiasi colesterolica 32
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease 32
Interazione Ospite-Batterio 32
Colite ulcerosa: problemi di istopatologia 32
Bone mineralization in celiac disease 32
Gut microbiota changes and chronic hepatitis C virus infection 31
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease 31
Follow-up clinico-endoscopico in 32 casi di adenoma maligno del colon 31
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum 30
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 30
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 30
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 30
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 30
Gastriti acute e croniche 30
Testing for serum IgG antibodies to Helicobacter pylori cytotoxin-associated protein detects children with higher grades of gastric inflammation 29
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 29
Bioactive IL-18 expression is up-regulated in Crohn's disease 29
Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacter Pylori infection 29
Helicobacter pylori transmission and Hepatitis A 29
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 28
Smoking, alcohol and coffe consumption, and H.pylori infection 28
Hepatitis C virus-induced hepatocellular carcinoma: a narrative review 28
Up-regulation of the IL-12 receptor beta-2 in Crohn's disease 28
Suggestion against an oral-oral route of transmission for Helicobacter pylori infection: a seroepidemiological study in a rural area. 28
The prevalence of Helicobacter pylori infection is not increased in children with celiac disease. 28
The therapy of cholesterol gallstones with bile acids 28
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 28
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 28
Isotypic analysis of specific antibody response in serum, saliva, gastric and rectal homogenates of Helicobacter pylori infected patients 27
Endoscopy personnel and Helicobacter pylori infection 27
Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission 27
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 27
Emorragia intestinale da diverticolo ulcerato del tenue. Descrizione di un caso clinico 27
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 27
Interleukin-12 is expressed and actively released by Crohn's desease intestinal lamina propria mononuclear cells 27
Metabolic effects of diet vs diet and silybin combined with phosphatidylcholine and vitamin E in overweight patients with non-alcoholic fatty liver disease 27
Patologie funzionali gastrointestinali 27
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists 27
Changes in Metabolic Parameters in Patients with Diabetic Kidney Disease Depending on the Status of D3 26
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 26
Changes in the mucosal expression of interleukin 15 in Helicobacter pylori associated gastritis 26
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 26
Update on Helicobacter pylori research. Diagnosis 26
Milk Thistle, Silybum marianum 26
Infezione da Helicobacter pylori e citochine 26
Author correction to Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells [Infect. Immun. 72, 9, (2004) 5019-5026] 26
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells 26
Totale 3.696
Categoria #
all - tutte 82.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 0 0 0 0 0 0 0 0 108 70
2020/2021229 35 11 3 38 20 17 15 26 47 10 4 3
2021/2022568 13 11 16 108 54 8 20 135 54 40 89 20
2022/20231.896 426 60 72 159 186 146 31 151 291 194 147 33
2023/2024952 223 98 71 63 32 219 34 61 45 26 27 53
2024/20252.381 386 182 176 67 173 388 192 155 421 90 151 0
Totale 6.279